Fifth Third Bancorp
AMRI

Fifth Third Bancorp’s Albany Molecular Research Inc AMRI Stock Holding History

Fifth Third Bancorp’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,000
Closed -$17K – 2367
2016
Q3 		$17K Buy
+1,000
New +$14.8K ﹤0.01% 1681
2016
Q1 		– Sell
-75
Closed -$1K – 2864
2015
Q4 		$1K Buy
75
+1
+1% +$19 ﹤0.01% 2697
2015
Q3 		$1K Buy
74
+30
+68% +$611 ﹤0.01% 2848
2015
Q2 		$1K Buy
44
+2
+5% +$39 ﹤0.01% 2824
2015
Q1 		$1K Buy
+42
New +$716 ﹤0.01% 2730

Other funds holding AMRI

PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Fifth Third Bancorp's AMRI Position: Q4 2016 in Review

Fifth Third Bancorp sold out of Albany Molecular Research Inc (AMRI) in Q4 2016, closing a stake of 1,000 shares — an estimated $17K sold.

Fifth Third Bancorp first reported a position in AMRI in Q1 2015 and held it in 5 quarters. The position peaked at $17K in Q3 2016. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.

  • Fifth Third Bancorp reported no remaining Albany Molecular Research Inc position as of Q4 2016 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,000 Albany Molecular Research Inc shares in Q4 2016, an estimated $17K.
  • Fifth Third Bancorp first reported a position in Albany Molecular Research Inc in Q1 2015 and held it in 5 quarters.
  • Fifth Third Bancorp's Albany Molecular Research Inc position peaked at $17K in Q3 2016.
  • 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.

Based on Fifth Third Bancorp's 13F filing for Q4 2016, filed 9 Feb 2017.